Inhibitory control of growth hormone secretion by somatostatin in rat pituitary GC cells: sst2 but not sst1 receptors are coupled to inhibition of single-cell intracellular free calcium concentrations

Neuroendocrinology

Volumn 76, Issue 2, 2002, Pages 99-110

  Cervia, Davide ^a   Petrucci, Cristina ^a   Bluet Pajot, Marie Thérèse ^b   Epelbaum, Jacques ^b   Bagnoli, Paola ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSERM   (France)

Author keywords

Ca2+ i oscillations; GC cell line; Growth hormone; Somatostatin; Somatostatin antagonists; Somatostatin receptors; Somatotropes

Indexed keywords

CALCIUM ION; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN; OCTAPEPTIDE; PERTUSSIS TOXIN; PROTEIN CYN 154806; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL SECRETION; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GROWTH HORMONE RELEASE; HORMONE ACTION; HORMONE DETERMINATION; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TUMOR CELL;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; GROWTH HORMONE; HORMONES; OCTREOTIDE; OLIGOPEPTIDES; PITUITARY GLAND; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 0036055478     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064424     Document Type: Article

References (46)

1. Characterization of a plasma membrane calcium oscillator in rat pituitary somatotrophs
2. 2+ influx and growth hormone secretion in pituitary somatotrophs
3. 2+ oscillations in rat somatotrophs
4. Endogenous pacemaker activity of rat tumor somatotrophs
5. Effects of chronic octreotide treatment on GH secretory dynamics and tumor growth in rats bearing an ectopic somatotroph (GC) tumor
6. Somatostatin and its receptor family
7. 2+ influx
8. i) and growth hormone release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin
9. Somatostatin-induced control of cytosolic free calcium in pituitary tumor cells
10. Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: Quantitative analysis by double-layer immunofluorescence confocal microscopy
11. Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells
12. (0) heterotrimer couples somatostatin receptors to voltage-gated calcium channels in RINm5F cells
13. 2+ current in the pituitary cell line AtT-20
14. Effects of somatostatin on intracellular calcium concentration in PC12 cells
15. Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells. Negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release
16. 2+ currents in rat insulinoma 1046-38 cells
17. Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures
18. Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs
19. 5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells
20. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
21. Characterization of human recombinant somatostatin receptors. 1. Radioligand binding studies
22. Identification and characterization of novel somatostatin antagonists
23. Identification and characterization of novel somatostatin antagonists
24. Spontaneous and repetitive calcium transients in C2C12 mouse myotubes during in vitro myogenesis
25. Development of selective antibodies against the human somatostatin receptor subtypes sst1-sst5
26. An enzyme immunoassay for rat growth hormone: Validation and application to the determination of plasma levels and in vitro release
27. Somatostatin actions on a protein kinase C-dependent growth hormone secretagogue cascade
28. 5 receptors
29. Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1)
30. + channels in MIN-6 cells
31. 2 receptor blockade with the novel cyclic octapeptide, CYN-154806
32. 2 receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat
33. Serum factors inhibit melanoma cell surface expression of type I and type II IGF receptors
34. Cell density-dependent proliferative effects of transforming growth factor (TGF)-β1, β2 and β3 in human chondrosarcoma cells HCS-2/8 are associated with changes in the expression of TGF-β receptor type I
35. Regulation of cell proliferation and angiotensin II type 2 receptors in R3T3 cells
36. The neurobiology of somatostatin
37. Signal transduction of the gonadotropin-releasing hormone receptor: Cross-talk of calcium, protein kinase C and arachidonic acid
38. 2+ oscillations in pancreatic acinar cells
39. 2 in GIP-stimulated insulin secretion
40. Growth hormone secretagogue actions on the pituitary gland: Multiple receptors for multiple ligands?
41. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland
42. Cortistatin, but not somatostatin, binds to growth hormone secretagogue receptors of human pituitary gland
43. Adenosine is an agonist of the growth hormone secretagogue receptor
44. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells
45. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin
46. i2-dependent activation of calcineurin and depriming of secretory granules